Preliminary testing of more than 850 schoolchildren in the Haitian town of Saut-d’Eau has shown only one child to be infected with the parasite that causes lymphatic filariasis (LF), a milestone in efforts to eradicate the debilitating disease from the island. The results, involving children from 38 schools in the community of 35,000 people 50 miles north of Port-au-Prince, mean that the University of Notre Dame Haiti Program likely will achieve its goal of eliminating LF, also known as elephantiasis, from Haiti by 2020.
We are fighting to eliminate lymphatic filariasis, a mosquito-borne disease endemic in Haiti, by 2020
See how the program is expanding our work in Haiti.
Learn more about the life and passion of Fr. Thomas Streit, C.S.C., the founder and director of the Haiti Program.
A note from the managing director regarding the 2015 MDA in Haiti
The initial response to our program need to fund DEC (diethylcarbamize citrate) pills in support of the Spring 2015 MDA cycle in Haiti has been substantial and most heartening. The cost of the drug is a little less than three cents per person treated. The following table illustrates the impact you can have as we seek to treat over five million people:
|$100||Will purchase DEC pills for about 4,000 Haitians|
|$500||Will purchase DEC pills for about 20,000 Haitians|
|$1000||Will purchase DEC pills for about 40,000 Haitians|
|$5000||Will purchase DEC pills for about 200,000 Haitians|
On behalf of Fr. Tom and all of the team, thanks so much for your partnership and generosity!
Yours in Notre Dame...and for Haiti,
Almost half of the population in endemic areas of Haiti suffer from Lymphatic Filariasis.
Founded in 1993, the University of Notre Dame Haiti Program seeks to achieve the historic goal of eliminating Lymphatic Filariasis (LF) in Haiti by 2020. LF, a mosquito-borne disease that affects over 2 million Haitians, is the second leading cause of long-term disfigurement and disability worldwide. It can be eliminated in Haiti through mass drug administration and the distribution of co-fortified salt. The Haiti Program is partnering with the Haitian Ministry of Health, corporations, and non-governmental organizations to forever eliminate the disease in Haiti and alleviate the suffering of Haitians infected with LF. Our innovative work also provides an exportable model for LF elimination in other developing nations.
Rev. Thomas Streit, C.S.C., founder and principal investigator for the Notre Dame Haiti Program and professor of biological sciences at the University of Notre Dame, recently published his reflections on the five-year anniversary of the devastating earthquake in Haiti that occurred on Jan. 12, 2010. The reflection piece, “5 years on, hope for Haiti” was published on CNN.com on Monday, Jan. 12.